VectivBio Holding AG
DelistedCIK 1836379fmd_18AR6DTE0FQ71SFPZT8JQAGHBBManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Dec 31, 2022, 6 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 27 |
| Research and development | 16 | 43 | 50 | 74 |
| Operating income | (24) | (57) | (87) | (81) |
| Interest expense | 0 | 1 | 0 | 3 |
| Income before taxes | (23) | (60) | (87) | (94) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (23) | (60) | (87) | (94) |
| Net income | (23) | (60) | (87) | (94) |